endocrinotherapy（doctor's choice）

DRUG2 trials

Sponsors

Biyun Wang, MD, Fujian Cancer Hospital

Conditions

Advanced Breast CancerBreast CancerHER2 + Breast Cancer

Phase 1

Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib

RecruitingNCT05464173

Biyun Wang, MDBreast Cancer

Start: 2022-07-01End: 2025-05-01Target: 44Updated: 2024-01-22

Phase 2

Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer

Not yet recruitingNCT07766772

Fujian Cancer HospitalHER2 + Breast Cancer, Advanced Breast Cancer

Start: 2026-09-30End: 2031-12-31Target: 50Updated: 2026-08-14